These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34596258)

  • 1. Development of a new pharmacokinetic model for target-concentration controlled infusion of vancomycin in critically ill patients.
    Bang JY; Kang HI; Lee HJ; Chong YP; Hong SK; Lee EK; Choi BM; Noh GJ
    Clin Exp Pharmacol Physiol; 2022 Feb; 49(2):202-211. PubMed ID: 34596258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a new pharmacokinetic model for target-concentration controlled infusion of cefoxitin as a prophylactic antibiotic in colorectal surgical patients.
    Kim KM; Kim SH; Yun HY; Jung J; Bang JY; Lee EK; Choi BM; Noh GJ
    Br J Clin Pharmacol; 2021 Dec; 87(12):4648-4657. PubMed ID: 33929765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of optimal loading and maintenance doses for continuous infusion of vancomycin in critically ill patients: Population pharmacokinetic modelling and simulations for improved dosing schemes.
    Vu DH; Nguyen DA; Delattre IK; Ho TT; Do HG; Pham HN; Dao XC; Tran NT; Nguyen GB; Van Bambeke F; Tulkens PM; Nguyen HA
    Int J Antimicrob Agents; 2019 Dec; 54(6):702-708. PubMed ID: 31600554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy.
    Economou CJP; Kielstein JT; Czock D; Xie J; Field J; Richards B; Tallott M; Visser A; Koenig C; Hafer C; Schmidt JJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2018 Aug; 52(2):151-157. PubMed ID: 29526606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achievement of Therapeutic Vancomycin Exposure With Continuous Infusion in Critically Ill Children.
    Genuini M; Oualha M; Bouazza N; Moulin F; Treluyer JM; Lesage F; Renolleau S; Benaboud S
    Pediatr Crit Care Med; 2018 Jun; 19(6):e263-e269. PubMed ID: 29394210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Mechanical Ventilation on the Pharmacokinetics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients.
    Medellín-Garibay SE; Romano-Moreno S; Tejedor-Prado P; Rubio-Álvaro N; Rueda-Naharro A; Blasco-Navalpotro MA; García B; Barcia E
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin Population Pharmacokinetics in Critically Ill Adults During Sustained Low-Efficiency Dialysis.
    Kanji S; Roberts JA; Xie J; Zelenitsky S; Hiremath S; Zhang G; Watpool I; Porteous R; Patel R
    Clin Pharmacokinet; 2020 Mar; 59(3):327-334. PubMed ID: 31471789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens.
    Roberts JA; Taccone FS; Udy AA; Vincent JL; Jacobs F; Lipman J
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2704-9. PubMed ID: 21402850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration.
    Escobar L; Andresen M; Downey P; Gai MN; Regueira T; Bórquez T; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2014 Aug; 44(2):163-7. PubMed ID: 24837847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population Pharmacokinetics and Dose Optimization of Vancomycin in Critically Ill Children.
    Sridharan K; Abbasi MY; Mulubwa M
    Eur J Drug Metab Pharmacokinet; 2021 Jul; 46(4):539-546. PubMed ID: 34156647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population Pharmacokinetics of Vancomycin in Pediatric Extracorporeal Membrane Oxygenation.
    Moffett BS; Morris J; Galati M; Munoz F; Arikan AA
    Pediatr Crit Care Med; 2018 Oct; 19(10):973-980. PubMed ID: 30063652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expected advantage of administering prophylactic antibiotics using target- concentration controlled infusion: Development of a new pharmacokinetic model of cefazolin.
    Kim KM; Jung J; Lee JM; Yang HS; Bang JY; Lee EK; Choi BM; Noh GJ
    Clin Exp Pharmacol Physiol; 2022 Jul; 49(7):731-739. PubMed ID: 35434816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
    Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
    Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin Pharmacokinetics in Obese Patients with Sepsis or Septic Shock.
    Masich AM; Kalaria SN; Gonzales JP; Heil EL; Tata AL; Claeys KC; Patel D; Gopalakrishnan M
    Pharmacotherapy; 2020 Mar; 40(3):211-220. PubMed ID: 31957057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of vancomycin pharmacokinetics in a heterogeneous critically ill population.
    Turner RB; Kojiro K; Won R; Chang E; Chan D; Elbarbry F
    Diagn Microbiol Infect Dis; 2018 Dec; 92(4):346-351. PubMed ID: 30025969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Sustained Low-Efficiency Dialysis.
    Rider TR; Silinskie KM; Hite MS; Bress J
    Pharmacotherapy; 2020 Oct; 40(10):1036-1041. PubMed ID: 32866291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
    Udy AA; Covajes C; Taccone FS; Jacobs F; Vincent JL; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2013 Jun; 41(6):564-8. PubMed ID: 23473944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
    Waineo MF; Kuhn TC; Brown DL
    J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-Dose Vancomycin Pharmacokinetics Versus Empiric Dosing on Area-Under-the-Curve Target Attainment in Critically Ill Patients.
    Flannery AH; Delozier NL; Effoe SA; Wallace KL; Cook AM; Burgess DS
    Pharmacotherapy; 2020 Dec; 40(12):1210-1218. PubMed ID: 33176005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study.
    Blot S; Koulenti D; Akova M; Bassetti M; De Waele JJ; Dimopoulos G; Kaukonen KM; Martin C; Montravers P; Rello J; Rhodes A; Starr T; Wallis SC; Lipman J; Roberts JA
    Crit Care; 2014 May; 18(3):R99. PubMed ID: 24887569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.